Paris, France

Odile Leclerc

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Sanofi-Aventis. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Odile Leclerc. Retrieved from https://idiyas.com/inventor/odile-leclerc-goad8hc6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Odile Leclerc: Innovator in Therapeutic Compounds

Introduction

Odile Leclerc is a prominent inventor based in Paris, France. She has made significant contributions to the field of therapeutic compounds, particularly through her innovative research and development efforts.

Latest Patents

Odile Leclerc holds a patent for "Azabicycloalkane derivatives, preparation thereof and use thereof in therapy." This invention relates to compounds of the general formula (I), wherein R, m, n, and o are defined within the patent documentation. The invention also encompasses a method for preparing these compounds and their application in therapeutic settings. She has 1 patent to her name.

Career Highlights

Throughout her career, Odile has worked with notable companies, including Sanofi and Sanofi-Aventis. Her work in these organizations has allowed her to advance her research and contribute to the development of new therapeutic solutions.

Collaborations

Odile has collaborated with esteemed colleagues such as Omar Ben Ayad and Alistair Lochead. These partnerships have further enriched her research and innovation efforts.

Conclusion

Odile Leclerc's contributions to the field of therapeutic compounds highlight her role as a leading inventor. Her innovative work continues to impact the medical and pharmaceutical industries positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…